IKNA: Ikena Oncology, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 67.56
Enterprise Value ($M) 14.71
Book Value ($M) 155.35
Book Value / Share 3.22
Price / Book 0.43
NCAV ($M) 143.73
NCAV / Share 2.98
Price / NCAV 0.47

Profitability (mra)
Return on Invested Capital (ROIC) -0.42
Return on Assets (ROA) -0.46
Return on Equity (ROE) -0.52

Liquidity (mrq)
Quick Ratio 15.85
Current Ratio 15.85

Balance Sheet (mrq) ($M)
Current Assets 161.17
Assets 172.78
Liabilities 17.43
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 9.16
Operating Income -75.42
Net Income -68.17

Cash Flow Statement (mra) ($M)
Cash From Operations -79.74
Cash from Investing 64.14
Cash from Financing 75.98

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-11 13G/A Fmr Llc 2.77 -70.96
02-14 13G/A Omega Fund VI, L.P. 4.70 0.00
02-14 13G/A Biotechnology Value Fund L P 9.90 90.53
02-14 13G/A Citadel Advisors Llc 0.40
10-19 13G Gilead Sciences Inc 6.70
09-21 13D/A Orbimed Advisors Llc 5.20 -6.54

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-12 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 18,429 170,450 10.81
2024-05-16 27,980 211,061 13.26
2024-05-15 40,393 149,576 27.01
2024-05-14 37,456 219,200 17.09
2024-05-13 36,001 269,300 13.37

(click for more detail)

Similar Companies
HCWB – HCW Biologics Inc. HRMY – Harmony Biosciences Holdings, Inc.
HROW – Harrow, Inc. IMRX – Immuneering Corporation
INAB – IN8bio, Inc.


Financial data and stock pages provided by
Fintel.io